Fernando Aranda

5.2k total citations
76 papers, 2.5k citations indexed

About

Fernando Aranda is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Fernando Aranda has authored 76 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Immunology, 40 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Fernando Aranda's work include Immunotherapy and Immune Responses (30 papers), CAR-T cell therapy research (19 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Fernando Aranda is often cited by papers focused on Immunotherapy and Immune Responses (30 papers), CAR-T cell therapy research (19 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Fernando Aranda collaborates with scholars based in Spain, France and United States. Fernando Aranda's co-authors include Guido Kroemer, Lorenzo Galluzzi, Laurence Zitvogel, Alexander Eggermont, Erika Vacchelli, Jérôme Galon, Catherine Sautès‐Fridman, Éric Tartour, Isabelle Cremer and Jitka Fučíková and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Fernando Aranda

74 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando Aranda Spain 28 1.5k 1.3k 644 240 189 76 2.5k
Beom K. Choi South Korea 29 1.9k 1.3× 882 0.7× 460 0.7× 146 0.6× 96 0.5× 70 2.6k
Timothy N. J. Bullock United States 31 2.1k 1.4× 1.4k 1.0× 798 1.2× 109 0.5× 210 1.1× 84 3.1k
Helena Harlin United States 16 1.6k 1.1× 1.3k 1.0× 742 1.2× 145 0.6× 114 0.6× 25 2.4k
Xuejun Fan United States 28 1.1k 0.8× 695 0.5× 906 1.4× 245 1.0× 178 0.9× 68 2.9k
Carmela De Santo United Kingdom 25 2.6k 1.7× 1.3k 0.9× 752 1.2× 172 0.7× 126 0.7× 40 3.6k
Catherine Koebel United States 8 2.3k 1.5× 1.9k 1.4× 783 1.2× 157 0.7× 214 1.1× 8 3.3k
Deepak Mittal Australia 21 1.7k 1.1× 1.7k 1.3× 807 1.3× 109 0.5× 248 1.3× 28 3.1k
Stefano Ugel Italy 30 3.3k 2.2× 2.1k 1.5× 1.1k 1.7× 161 0.7× 267 1.4× 63 4.6k
Antonella Sistigu Italy 24 1.5k 1.0× 1.6k 1.2× 825 1.3× 123 0.5× 316 1.7× 38 2.9k
Nicole E. Scharping United States 18 2.2k 1.5× 1.4k 1.0× 1.0k 1.6× 193 0.8× 212 1.1× 26 3.4k

Countries citing papers authored by Fernando Aranda

Since Specialization
Citations

This map shows the geographic impact of Fernando Aranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Aranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Aranda more than expected).

Fields of papers citing papers by Fernando Aranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Aranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Aranda. The network helps show where Fernando Aranda may publish in the future.

Co-authorship network of co-authors of Fernando Aranda

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Aranda. A scholar is included among the top collaborators of Fernando Aranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Aranda. Fernando Aranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berraondo, Pedro, Fernando Aranda, Iñaki Eguren‐Santamaría, et al.. (2025). Immunocytokines and cytokine neutralization for cancer immunotherapy. Trends in cancer. 11(8). 790–805. 3 indexed citations
2.
Belsúe, Virginia, et al.. (2024). Tumor slice culture system for ex vivo immunotherapy studies. Methods in cell biology. 189. 55–69. 1 indexed citations
3.
Fernández-Sendin, Myriam, Maite Álvarez, Fernando Aranda, et al.. (2024). Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C. Journal for ImmunoTherapy of Cancer. 12(4). e008287–e008287. 2 indexed citations
4.
Olivera, Irene, Assunta Cirella, Myriam Fernández-Sendin, et al.. (2023). Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis. Journal for ImmunoTherapy of Cancer. 11(11). e006702–e006702. 8 indexed citations
5.
Cirella, Assunta, Myriam Fernández-Sendin, Irene Olivera, et al.. (2022). Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8 + T cells eradicates peritoneal metastases in mouse models. OncoImmunology. 12(1). 2147317–2147317. 9 indexed citations
6.
Cirella, Assunta, Myriam Fernández-Sendin, Inmaculada Rodríguez, et al.. (2022). Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis. OncoImmunology. 11(1). 2098657–2098657. 2 indexed citations
7.
Fernández-Sendin, Myriam, Assunta Cirella, Álvaro Teijeira, et al.. (2021). Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications. Cancers. 13(5). 963–963. 12 indexed citations
8.
Álvarez, Maite, Carmen Molina, Carlos E. de Andrea, et al.. (2021). Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy. Journal for ImmunoTherapy of Cancer. 9(11). e002953–e002953. 29 indexed citations
9.
Vásquez, Marcos, Maite Álvarez, Itziar Otano, et al.. (2021). Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors. Journal for ImmunoTherapy of Cancer. 9(7). e001587–e001587. 13 indexed citations
10.
Català, Cristina, et al.. (2020). Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents. Cells. 9(12). 2589–2589. 21 indexed citations
11.
Vásquez, Marcos, Marta Consuegra‐Fernández, Fernando Aranda, et al.. (2019). Treatment of Experimental Autoimmune Encephalomyelitis by Sustained Delivery of Low-Dose IFN-α. The Journal of Immunology. 203(3). 696–704. 7 indexed citations
12.
Vásquez, Marcos, et al.. (2017). Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR‐B1. European Journal of Immunology. 47(7). 1108–1118. 30 indexed citations
13.
Consuegra‐Fernández, Marta, Mario Martínez‐Florensa, Fernando Aranda, et al.. (2017). Relevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and Tolerance. Frontiers in Immunology. 8. 594–594. 10 indexed citations
14.
Bloy, Norma, Aitziber Buqué, Fernando Aranda, et al.. (2015). Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology. 4(5). e1026531–e1026531. 32 indexed citations
15.
Vacchelli, Erika, Fernando Aranda, Norma Bloy, et al.. (2015). Trial Watch—Immunostimulation with cytokines in cancer therapy. OncoImmunology. 5(2). e1115942–e1115942. 44 indexed citations
16.
Aranda, Fernando, Norma Bloy, Lorenzo Galluzzi, Guido Kroemer, & Laura Senovilla. (2014). Vitamin B6 improves the immunogenicity of cisplatin-induced cell death. OncoImmunology. 3(9). e955685–e955685. 16 indexed citations
17.
Vacchelli, Erika, Fernando Aranda, Alexander Eggermont, et al.. (2014). Trial watch: IDO inhibitors in cancer therapy. OncoImmunology. 3(10). e957994–e957994. 288 indexed citations
18.
Aranda, Fernando, Diana Llópiz, Nancy Díaz‐Valdés, et al.. (2011). Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors. Cancer Research. 71(9). 3214–3224. 63 indexed citations
19.
Díaz‐Valdés, Nancy, Javier Dotor, Fernando Aranda, et al.. (2010). Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGFβ1 in Melanoma Enhances Tumor Infiltration and Immunosuppression. Cancer Research. 71(3). 812–821. 55 indexed citations
20.
Aranda, Fernando, et al.. (2005). La soledad del corredor de fondo.. 5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beom K. Choi Breakdown of academic impact, for papers by Timothy N. J. Bullock Breakdown of academic impact, for papers by Helena Harlin Breakdown of academic impact, for papers by Xuejun Fan Breakdown of academic impact, for papers by Carmela De Santo Breakdown of academic impact, for papers by Catherine Koebel Breakdown of academic impact, for papers by Deepak Mittal Breakdown of academic impact, for papers by Stefano Ugel Breakdown of academic impact, for papers by Antonella Sistigu Breakdown of academic impact, for papers by Nicole E. Scharping
Rankless by CCL
2026